Rinvoq ER 30 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FNN9Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,548
Award facts
- Contract value 100% obligated
- $14,547.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,547.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of RINVOQ ER 30 mg, with an ultimate completion date of December 3, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026. AmerisourceBergen is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, and serves as a critical supplier of medications and medical supplies to military and veteran healthcare systems.
RINVOQ ER is a prescription immunosuppressant used to treat rheumatoid arthritis and other inflammatory conditions, with deliverables to be fulfilled at AmerisourceBergen's Conshohocken location. The award demonstrates the contractor's ongoing capability to meet federal procurement requirements through the DLA's pharmaceutical prime vendor model, which enables efficient supply chain management across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare customers. AmerisourceBergen's extensive portfolio of federal pharmaceutical contracts reflects its position as a cornerstone supplier within the Defense Logistics Agency's medical supply network.
Quick answers
Who was awarded contract SPE2DR26FNN9Y?
SPE2DR26FNN9Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26FNN9Y worth?
The government has obligated $14,548 on SPE2DR26FNN9Y.
Is contract SPE2DR26FNN9Y an order under another contract?
Yes. SPE2DR26FNN9Y is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNN9Y competed?
The extent of competition for SPE2DR26FNN9Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award